Benutzerspezifische Werkzeuge

Publikationen 2018

  1. Borkowetz A, Renner T, Platzek I, Toma M, Herout R, Baunacke M, Groeben C, Huber J, Laniado M, Baretton GB, Froehner M, Zastrow S, Wirth MP (2018). Evaluation of magnetic resonance imaging/ultrasound- fusion biopsy in patients with low- risk prostate cancer under active surveillance undergoing surveillance biopsy. Urol Int 100:155-163
  2. Borkowetz A, Hadaschik B, Platzek I, Toma M, Torsev G, Renner T, Herout R, Baunacke M, Laniado M, Baretton G, Radtke JP, Kesch C, Hohenfellner M, Froehner M, Schlemmer HP, Wirth M, Zastrow S (2018).Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naïve patients. BJU Int 121:53-60
  3. Borkowetz A, Renner T, Platzek I, Toma M, Herout R, Baunacke M, Groeben C, Huber J, Laniado M, Baretton G, Froehner M, Zastrow S, Wirth MP (2018). Evaluation of transperineal magnetic resonance imaging/ultrasound- fusion biopsy compared to transrectal systematic biopsy in the prediction of tumour aggressiveness in patients with previously negative biopsy. Urol Int 102:20-26 
  4. Brandt D, Sohr E, Pablik J, Schnabel A, Kapplusch F, Mäbert K, Girschick JH, Morbach H, Thielemann F, Hofmann SR, Hedrich CM (2018). CD14+ monocytes contribute to inflammation in chronic nonbacterial osteomyelitis (CNO) through increased NLRP3 inflammasome expression. Clin Immunol 196:77-84  
  5. Brosch M, Kattler K, Herrmann A, Von Schönfels W, Nordström K, Seehofer D, Damm G, Becker T, Zeissig S, Nehring S, Reichel F, Moser V, Thangapandi RV, Stickel F, Baretton G, Röcken C, Muders M, Matz-Soja M, Krawczak M, Gasparoni G, Hartmann H, Dahl A, Schafmayer C, Walter J, Hampe J (2018). Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic control. Nat Commun 9:4150
  6. Capper D, Engel NW, Stichel D, Lechner M, Glöss S, Schmid S, Koelsche C, Schrimpf D, Niesen J, Wefers AK, Jones DTW, Sill M, Weigert O, Ligon KL, Olar A, Koch A, Forster M, Moran S, Tirado OM, Sáinz-Jaspeado M, Mora J, Esteller M, Alonso J, Del Muro XG, Paulus W, Felsberg J, Reifenberger G, Glatzel M, Frank S, Monoranu CM, Lund VJ, Von Deimling A, Pfister S, Buslei R, Ribbat-Idel J, Perner S, Gudziol V, Meinhardt M, Schüller U (2018). DNA methylation-based reclassification of olfactory neuroblastoma. Acta Neuropathol 136:255-271
  7. Casadonte R, Kriegsmann M, Perren A, Baretton G, Deininger SO, Kriegsmann K, Welsch T, Pilarsky C, Kriegsmann J (2018). Development of a class prediction model to discriminate pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumor by MALDI mass spectrometry imaging. Proteom Clin Appl:e1800046
  8. Cordes N, Ney M, Beleites T, Aust DBaretton G, Thames H, Baumann M, Krause M, Löck S, Appold S(2018). Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy. PlosOne 13:e0209479
  9. Froehner M, Jahn S, Plodeck V, Laniado M, Wirth MP (2018). Chronically infected urachal remnant mimicking tumor with peritoneal carcinomatosis. Urology 116:e3 - e4
  10. Galli R, Meinhardt M, Koch E, Schackert G, Steiner G, Kirsch M, Uckermann O (2018). Optical molecular imaging of corpora amylacea in human brain tissue. Biomed Eng-Biomed Te 63:579 – 585
  11. Gieldon L, Masjkur JR, Richter S, Därr R, Lahera M, Aust D, Zeugner S, Rump A, Hackmann K, Tzschach A, Januszewicz A, Prejbisz A, Eisenhofer G, Schrock E, Robledo M, Klink B (2018). Next-generation panel sequencing identifies NF1 germline mutations in three patients with pheochromocytoma but no clinical diagnosis of neurofibromatosis type 1. Eur J Endocrinol 178:K1 - K9
  12. Haehner A, Hummel T, Heinritz W, Krueger S, Meinhardt M, Whitcroft KL, Sabatowski R, Gossrau G (2018). Mutation in Nav 1.7 causes high olfactory sensitivity. Eur J Pain 22:1767 – 1773
  13. Heberling U, Koch R, Hübler M, Baretton GB, Hakenberg OW, Wirth MP, Froehner M (2018). Gender and mortality after radical cystectomy: competing risk analysis. Urol Int 101:293 – 299
  14. Henkel  J, Coleman CD, Schraplau A, Jöhrens K, Weiss TS, Jonas W, Schürmann A, Püschel GP (2018). Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model. Sci Rep UK 8:16127
  15. Henkel J, Alfine E, Saín J, Jöhrens K, Weber D, Castro JP, König J, Stuhlmann C, Vahrenbrink M, Jonas W, Kleinridders A, Püschel GP (2018). Soybean oil- derived poly-unsaturated fatty acids enhance liver damage in NAFLD induced by dietary cholesterol. Nutrients 10:E1326
  16. Hirsch B, Endris V, Lassmann S, Weichert W, Pfarr N, Schirmacher P, Kovaleva V, Werner M, Bonzheim I, Fend F, Sperveslage J, Kaulich K, Zacher A, Reifenberger G, Köhrer K, Stepanow S, Lerke S, Mayr TAust DEBaretton G, Weidner S, Jung A, Kirchner T, Hansmann ML, Burbat L, Von Der Wall E, Dietel M, Hummel M(2018). Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics. Virchows Arch 472:557 - 565
  17. Jarosch ASommer U, Bogner A, Reißfelder C, Weitz J, Krause M, Folprecht G, Baretton GBAust DE (2018). Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer. Oncoimmunology 7:e1393133
  18. Juratli TA, Stasik S, Zolal A, Schuster C, Richter S, Daubner D, Juratli MA, Thowe  R, Hennig S, Makina M, Meinhardt M, Lautenschlaeger T, Schackert G, Krex D, Thiede C (2018). TERT promoter mutation detection in cell-free tumor-derived DNA in patients with IDH wild-type glioblastomas: a pilot prospective study. Clin Cancer Res 24:5282 - 5291
  19. Juratli TA, McCabe D, Nayyar N, Williams EA, Silverman IM, Tummala SS, Fink AL, Baig A, Martinez-Lage M, Selig MK, Bihun IV, Shankar GM, Penson T, Lastrapes M, Daubner D, Meinhardt M, Hennig S, Kaplan AB, Fujio S, Kuter BM, Bertalan MS, Miller JJ, Batten JM, Ely HA, Christiansen J, Baretton GB, Stemmer-Rachamimov AO, Santagata S, Rivera MN, Barker FG, Schackert G, Wakimoto H, Iafrate AJ, Carter SL, Cahill DP, Brastianos PK(2018). DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome. Acta Neuropathol 136:779 - 792
  20. Kahlert C, Distler M, Aust D, Gieldon L, Weitz J, Welsch T (2018). Early stage pancreatic cancer. CHIRURG 89:257 - 265
  21. Kohler A, Welsch T, Sturm AKBaretton GB, Reissfelder C, Weitz J, Riediger C (2018).Primary choriocarcinoma of the liver: a rare, but important differential diagnosis of liver lesions. J Surg Case Rep 2018:rjy068
  22. Kubasch AS, Wehner R, Bazzurri S, Tunger A, Stasik S, Garzarolli M, Meinel J, Baretton G, Meier F, Thiede C, Schmitz M, Platzbecker U (2018). Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia. Blood Adv 2:1187 - 1190
  23. Langton K, Gruber M, Masjkur J, Steenblock C, Peitzsch M, Meinel J, Lenders J, Bornstein S, Eisenhofer G(2018). Hypertensive crisis in pregnancy due to a metamorphosing pheochromocytoma with postdelivery Cushing's syndrome. Gynecol Endocrinol 34:20 - 24
  24. Linge A, Schötz U, Löck S, Lohaus F, Von Neubeck C, Gudziol V, Nowak A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Bunea H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Lauber K, Pigorsch S, Combs SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Krause M, Belka C, Baumann M (2018). Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC. Radiother Oncol 127:27 - 35
  25. Miehlke S, Aust D, Mihaly E, Armerding P, Böhm G, Bonderup O, Fernández-Bañares, F, Kupcinskas J, Munck LK, Rehbehn KU, Nacak T, Greinwald R, Münch A (2018). Efficacy and safety of budesonide, vs mesalazine or placebo, as induction therapy for lymphocytic colitis. Gastronenterology 155:1795 - 1804.e3
  26. Rezaei M, Cao J, Friedrich K, Kemper B, Brendel OGrosser M, Adrian M, Baretton G, Breier G, Schnittler HJ (2018). The expression of VE-cadherin in breast cancer cells modulates cell dynamics as a function of tumor differentiation and promotes tumor-endothelial cell interactions. Histochem Cell Biol 149:15 - 30
  27. Richter S, Gieldon L, Pang Y, Peitzsch M, Huynh T, Leton R, Viana B, Ercolino T, Mangelis A, Rapizzi E, Menschikowski M, Aust D, Kroiss M, Beuschlein F, Gudziol V, Timmers HJ, Lenders J, Mannelli M, Cascon A, Pacak K, Robledo M, Eisenhofer G, Klink B (2018). Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma. Genet Med 21:705-717
  28. Ritter J, Zimmermann K, Jöhrens K, Mende S, Seegebarth A, Siegmund B, Hennig S, Todorova K, Rosenwald A, Daum S, Hummel M, Schumann M (2018). T-cell repertoires in refractory coeliac disease. Gut 67:644 - 653
  29. Roy S, Bag AK, Dutta S, Polavaram NS, Islam R, Schellenburg S, Banwait J, Guda C, Ran S, Hollingsworth MA, Singh RK, Talmadge JE, Muders MH, Batra SK, Datta K (2018). Macrophage-derived neuropilin-2 exhibits novel tumor-promoting functions. Cancer Res 78:5600 - 5617
  30. Scheel AH, Baenfer G, Baretton G, Dietel M, Diezko R, Henkel T, Heukamp LC, Jasani B, Jöhrens K, Kirchner T, Lasitschka F, Petersen I, Reu S, Schildhaus HU, Schirmacher P, Schwamborn K, Sommer U, Stoss O, Tiemann M, Warth A, Weichert W, Wolf J, Büttner R, Rüschoff J(2018). Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer. Histopathol 72:449 - 459
  31. Scheel AH, Penault-Llorca F, Hanna W, Baretton G, Middel P, Burchhardt J, Hofmann M, Jasani B, Rüschoff J (2018). Physical basis of the 'magnification rule' for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer. Diagn Pathol 13:19
  32. Schleussner  N, Merkel O, Costanza M, Liang HC, Hummel F, Romagnani C, Durek P, Anagnostopoulos I, Hummel M, Jöhrens K, Niedobitek A, Griffin PR, Piva R, Sczakiel HL, Woessmann W, Damm-Welk C, Hinze C, Stoiber D, Gillissen B, Turner SD, Kaergel E, Von Hoff L, Grau M, Lenz G, Dörken B, Scheidereit C, Kenner L, Janz M, Mathas S (2018). The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma. Leukemia 32:1994 - 2007
  33. Schmidt S, Linge A, Zwanenburg A, Leger S, Lohaus F, Krenn C, Appold S, Gudziol V, Nowak A, Von Neubeck C, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Bunea H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs  SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Baumann M, Krause M, Löck S (2018). Development and validation of a gene signature for patients with head and neck carcinomas treated by postoperative radio(chemo)therapy. Clin Cancer Res 24:1364 - 1374
  34. Seidlitz T, Merker SR, Rothe A, Zakrzewski F, Von Neubeck C, Grützmann K, Sommer U, Schweitzer C, Schölch S, Uhlemann H, Gaebler AM, Werner K, Krause M, Baretton GB, Welsch T, Koo BK, Aust DE, Klink B, Weitz J, Stange DE (2018). Human gastric cancer modelling using organoids. Gut 68:207 - 217
  35. Solimena M, Schulte AM, Marselli L, Ehehalt F, Richter D, Kleeberg M, Mziaut H, Knoch KP, Parnis J, Bugliani M, Siddiq A, Jörns A, Burdet F, Liechti R, Suleiman M, Margerie D, Syed F, Distler M, Grützmann R, Petretto E, Moreno-Moral A, Wegbrod C, Sönmez A, Pfriem K, Friedrich A, Meinel J, Wollheim CB, Baretton GB, Scharfmann R, Nogoceke E, Bonifacio E, Sturm D, Meyer-Puttlitz B, Boggi U, Saeger HD, Filipponi F, Lesche M, Meda  P, Dahl A, Wigger L, Xenarios I, Falchi M, Thorens B, Weitz J, Bokvist K, Lenzen S, Rutter GA, Froguel P, Von Bülow M, Ibberson M, Marchetti P (2018). Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes. Diabetologia 61:641 - 657
  36. Thiele S, Zimmer A, Göbel A, Rachner TD, Rother S, Fuessel S, Froehner M, Wirth MP, Muders MHBaretton GB, Jakob F, Rauner M, Hofbauer LC (2018). Role of WNT5A receptors FZD5 and RYK in prostate cancer cells. Oncotarget 9:27293 - 27304
  37. Uckermann O, Yao W, Juratli TA, Galli R, Leipnitz E, Meinhardt M, Koch E, Schackert G, Steiner G, Kirsch M (2018). IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy. J Neuro Oncol 139:261 - 268
  38. Ullrich M., Liers J, Peitzsch M, Feldmann A, Bergmann R, Sommer U, Richter S, Bornstein SR, Bachmann M, Eisenhofer G, Ziegler CG, Pietzsch J (2018). Strain-specific metastatic phenotypes in pheochromocytoma allograft mice. Endocr Relat Cancer 25:993 - 1004
  39. Welsch T, Seifert A, Müssle B, Distler M, Aust DE, Weitz J (2018). The "T" now matters:the eighth edition of the union for international cancer control classification of pancreatic adenocarcinoma. Ann Surg 268:e36 - e37
  40. Werthmann PG, Inter P, Welsch T, Sturm AK, Grützmann R, Debus M, Sterner MG, Kienle GS (2018). Long-term tumor-free survival in a metastatic pancreatic carcinoma patient with FOLFIRINOX/Mitomycin, high-dose, fever inducing Viscum album extracts and subsequent R0 resection: a case report. Medicine 97:e13243
  41. Zeissig S, Schmelz R, Brückner S, Aust DEBaretton GB, Hampe J (2018). Direct endoscopy and diagnosis of adenocarcinoma following metal stent-based drainage of a pancreatic cyst. Endoscopy 50:E72 - E73
  42. Zinnall U, Weyerer V, Compérat E, Camparo P, Gaisa NT, Knuechel-Clarke R, Perren, A, Lugli A, Toma MBaretton G, Kristiansen G, Wirtz RM, Cheng L, Wullich B, Stoehr  R, Hartmann A, Bertz S (2018). Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype. Hum Pathol 80:55 - 64